Cargando…
The role of lncRNA H19 in tumorigenesis and drug resistance of human Cancers
Systemic therapy is one of the most significant cancer treatments. However, drug resistance often appears and has become the primary cause of cancer therapy failure. Regulation of drug target, drug metabolism and drug efflux, cell death escape (apoptosis, autophagy, et al.), epigenetic changes, and...
Autores principales: | Zhang, Xun, Luo, Mingpeng, Zhang, Jiahang, Guo, Bize, Singh, Shreya, Lin, Xixi, Xiong, Hanchu, Ju, Siwei, Wang, Linbo, Zhou, Yulu, Zhou, Jichun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555214/ https://www.ncbi.nlm.nih.gov/pubmed/36246634 http://dx.doi.org/10.3389/fgene.2022.1005522 |
Ejemplares similares
-
Survival-Related lncRNA Landscape Analysis Identifies LINC01614 as an Oncogenic lncRNA in Gastric Cancer
por: Wu, Huijie, et al.
Publicado: (2021) -
The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy
por: Wang, Ji, et al.
Publicado: (2019) -
LncRNA LUCRC Regulates Colorectal Cancer Cell Growth and Tumorigenesis by Targeting Endoplasmic Reticulum Stress Response
por: Tang, Guo-Hui, et al.
Publicado: (2020) -
Risk Model and Immune Signature of m7G-Related lncRNA Based on Lung Adenocarcinoma
por: Zhang, Chuanhao, et al.
Publicado: (2022) -
LncRNA H19 Impairs Chemo and Radiotherapy in Tumorigenesis
por: Garcia-Padilla, Carlos, et al.
Publicado: (2022)